Altacor Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Altacor Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011840
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Altacor Ltd (Altacor) is an ophthalmology company that develops and markets products for chronic eye conditions. The company offers prescription and retail ophthalmology products. Its products comprise liquid gel, eye drop, eye mask, eyelid cleaner, nutritional supplement, and others. Altacor’s products are used for dry eye syndrome, blepharitis and age-related macular degeneration treatments. The company also offers laser surgery and filtering microsurgery to overcome glaucoma; ophthalmic surgery and cataract surgery. It sells its products through a network of distributors in the UK and other European countries. Altacor is headquartered in Cambridge, the UK.

Altacor Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Altacor Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Altacor Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Altacor Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Altacor Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Altacor Secures US$3 Million In Second Tranche Of Venture Financing 11
Private Equity 13
Esperante Acquires Altacor from Beringea 13
Partnerships 14
Altacor Enters Into Co-Promotion Agreement With Norgine For Clinitas Dry Eye Product 14
Proximagen And Altacor Enter Into R&D Agreement For Treatment Of Glaucoma 15
Licensing Agreements 16
Altacor Enters Into Licensing Agreement With OphthalmoPharma For Latanoprost CD And Cyclosporin A Prodrug 16
Acquisition 17
NicOx Completes Acquisition Of 11.8% Stake In Altacor For US$3 Million 17
Altacor Ltd – Key Competitors 19
Altacor Ltd – Key Employees 20
Altacor Ltd – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Altacor Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Altacor Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Altacor Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Altacor Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Altacor Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Altacor Secures US$3 Million In Second Tranche Of Venture Financing 11
Esperante Acquires Altacor from Beringea 13
Altacor Enters Into Co-Promotion Agreement With Norgine For Clinitas Dry Eye Product 14
Proximagen And Altacor Enter Into R&D Agreement For Treatment Of Glaucoma 15
Altacor Enters Into Licensing Agreement With OphthalmoPharma For Latanoprost CD And Cyclosporin A Prodrug 16
NicOx Completes Acquisition Of 11.8% Stake In Altacor For US$3 Million 17
Altacor Ltd, Key Competitors 19
Altacor Ltd, Key Employees 20

★海外企業調査レポート[Altacor Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vietnam Dairy Products Joint Stock Co:戦略・SWOT・企業財務分析
    Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report Summary Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • PPG Industries Inc (PPG):企業の財務・戦略的SWOT分析
    PPG Industries Inc (PPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • RaQualia Pharma Inc (4579):製薬・医療:M&Aディール及び事業提携情報
    Summary RaQualia Pharma Inc (RaQualia) is a drug development company that discovers and develops pharmaceutical compounds. The company offers products such as anidulafungin, ziprasidone, dalbavancin, 5-HT2B antagonist, motilin receptor agonist, potassium-competitive acid blockerand 5-HT4 partial ago …
  • Suzuki Motor Corporation:企業の戦略・SWOT・財務分析
    Suzuki Motor Corporation - Strategy, SWOT and Corporate Finance Report Summary Suzuki Motor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Schweizerische Rettungsflugwacht:企業の戦略的SWOT分析
    Schweizerische Rettungsflugwacht - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • NextEra Energy Inc (NEE)-エネルギー分野:企業M&A・提携分析
    Summary NextEra Energy, Inc. (NEE), formerly FPL Group, Inc., is an energy company that generates, transmits and distributes electricity together with its subsidiaries. The company generates power through various sources such as nuclear, coal, oil and natural gas-fired facilities, and hydro power pl …
  • Nordea Bank AB:企業のM&A・事業提携・投資動向
    Nordea Bank AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nordea Bank AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • curasan AG (CUR):企業の製品パイプライン分析2018
    Summary curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, ora …
  • KPJ Healthcare Berhad (KPJ):企業の財務・戦略的SWOT分析
    Summary KPJ Healthcare Berhad (KPJ) is a healthcare service provider that offers medical services. The center offers services in the areas of anaesthesiology, cardiology and cardiothoracic surgery, child psychiatry, clinic pathology, occupational health services, orthopaedic and trauma surgery, diet …
  • University of Leicester-製薬・医療分野:企業M&A・提携分析
    Summary University of Leicester (UOL) is an educational service provider that offers undergraduate, postgraduate, distance learning and part-time programs. The university offers educational and research services in various disciplines such as mathematics, biochemistry, medicine, astrophysics, geneti …
  • Bionomics Ltd (BNO):企業の財務・戦略的SWOT分析
    Summary Bionomics Ltd (Bionomics) is a biopharmaceutical company that discovers and develops treatments for cancer, and central nervous system disorders such as anxiety, depression and Alzheimer's disease. The company provides pipeline products such as BNC210, BNC 105, BNC101 and BNC375, among other …
  • Compagnie Financiere Richemont SA (CFR):企業の財務・戦略的SWOT分析
    Compagnie Financiere Richemont SA (CFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • SKF AB:企業の戦略・SWOT・財務情報
    SKF AB - Strategy, SWOT and Corporate Finance Report Summary SKF AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Lee’s Pharmaceutical Holdings Ltd (950):企業の財務・戦略的SWOT分析
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a bio pharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematolog …
  • Terex Corporation:企業の戦略・SWOT・財務情報
    Terex Corporation - Strategy, SWOT and Corporate Finance Report Summary Terex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • William Hill plc (WMH):企業の財務・戦略的SWOT分析
    William Hill plc (WMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • JSC Halyk Bank:企業の戦略・SWOT・財務情報
    JSC Halyk Bank - Strategy, SWOT and Corporate Finance Report Summary JSC Halyk Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Franklin Covey Co. (FC):企業の財務・戦略的SWOT分析
    Franklin Covey Co. (FC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Stockmann plc (STCBV):企業の財務・戦略的SWOT分析
    Stockmann plc (STCBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Norinchukin Bank:企業の戦略・SWOT・財務分析
    The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆